| Autor: |
El Fattah El Malatawy, Mohammed Abd, Bahaa El Din, Mohamed Mohamed, Mohamed, Eslam Safwat, Faheem, Heba Ahmed, Shawkey Isac, Shadi Emad |
| Předmět: |
|
| Zdroj: |
QJM: An International Journal of Medicine; 2024 Supplement, Vol. 117, pi124-i125, 2p |
| Abstrakt: |
Background: Hepatocellular carcinoma (HCC) is the sixth most common cancer and the third cause of cancer-related mortality world-wide. The incidence of HCC is on the increase, and it is a major threat to our modern life. Epidemiological studies have indicated that HCC are related to chronic hepatitis B virus (HBV) and chronic hepatitis C virus (HCV) infection. Aim of the Work: To detect prevalence, patterns, perioperative factors and outcome of recurrence of HCC after living donor liver transplantation. Patients and Methods: This was a cross sectional study based on the review of medical records of all patients undergoing LT at Ain Shams Centre of Transplantation, between January 1, 2010, and December 31, 2018. Results: we detected prevalence, patterns, perioperative factors and outcome of recurrence of HCC after living donor liver transplantation. Conclusion: Oral lactoferrin could not be used as a substitute to totally replace IV ferrous sulphate in treating iron deficiency anemia in end stage renal disease (ESRD) on dialysis. Oral lactoferrin could not even control Hb level constant without dropping in patients with end stage renal disease (ESRD). Oral lactoferrin had some gastrointestinal effects on some patients which did not allow compliance on the medication. [ABSTRACT FROM AUTHOR] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
